737 related articles for article (PubMed ID: 19250932)
21. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
22. Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels.
Li L; Yang G; Li Q; Tan X; Liu H; Tang Y; Boden G
Diabetes Obes Metab; 2008 Sep; 10(10):921-30. PubMed ID: 18093209
[TBL] [Abstract][Full Text] [Related]
23. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
24. Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo.
Wu N; Lu Y; He B; Zhang Y; Lin J; Zhao S; Zhang W; Li Y; Han P
Diabetes Res Clin Pract; 2010 Dec; 90(3):288-96. PubMed ID: 20855122
[TBL] [Abstract][Full Text] [Related]
25. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
Ye JM; Frangioudakis G; Iglesias MA; Furler SM; Ellis B; Dzamko N; Cooney GJ; Kraegen EW
Endocrinology; 2002 Dec; 143(12):4527-35. PubMed ID: 12446579
[TBL] [Abstract][Full Text] [Related]
26. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
27. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats.
Li PP; Shan S; Chen YT; Ning ZQ; Sun SJ; Liu Q; Lu XP; Xie MZ; Shen ZF
Br J Pharmacol; 2006 Jul; 148(5):610-8. PubMed ID: 16751799
[TBL] [Abstract][Full Text] [Related]
28. 10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes.
Zini E; Osto M; Konrad D; Franchini M; Sieber-Ruckstuhl NS; Kaufmann K; Guscetti F; Ackermann M; Lutz TA; Reusch CE
Horm Metab Res; 2010 May; 42(5):340-7. PubMed ID: 20162504
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.
Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
[TBL] [Abstract][Full Text] [Related]
32. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
[TBL] [Abstract][Full Text] [Related]
33. Reduced cardiotropic response to insulin in spontaneously hypertensive rats: role of peroxisome proliferator-activated receptor-gamma-initiated signaling.
Zhang H; Li J; Li R; Zhang Q; Ma H; Ji Q; Guo W; Wang H; Lopez BL; Christopher TA; Ma X; Gao F
J Hypertens; 2008 Mar; 26(3):560-9. PubMed ID: 18300869
[TBL] [Abstract][Full Text] [Related]
34. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
[TBL] [Abstract][Full Text] [Related]
35. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Qi Z; Xue J; Zhang Y; Wang H; Xie M
Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
[TBL] [Abstract][Full Text] [Related]
36. PPAR-gamma-independent inhibitory effect of rosiglitazone on glucose synthesis in primary cultured rabbit kidney-cortex tubules.
Derlacz RA; Hyc K; Usarek M; Jagielski AK; Drozak J; Jarzyna R
Biochem Cell Biol; 2008 Oct; 86(5):396-404. PubMed ID: 18923541
[TBL] [Abstract][Full Text] [Related]
37. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
38. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats.
Yadav H; Jain S; Yadav M; Sinha PR; Prasad GB; Marotta F
Dig Liver Dis; 2009 Jul; 41(7):500-8. PubMed ID: 19196556
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β/NF-κB expression in liver.
Zhou X; You S
Pancreas; 2014 Nov; 43(8):1291-8. PubMed ID: 25036911
[TBL] [Abstract][Full Text] [Related]
40. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
